Mylan Quality

At Mylan, whether it’s a medication for millions or for a handful of people, our priorities are to meet or exceed industry standards. 

Because there’s nothing generic about our standards. Our internal teams conduct reviews of all products, start to finish. No matter where in the world they are made. In fact, we championed a law that empowers the FDA to biennially inspect all manufacturing facilities around the world that supply the U.S. market.

"We have one global quality standard, because we know where our priorities are. It all starts and ends with you."
Robert J. Coury Executive Chairman

To us, trust goes beyond our global quality standards. It’s all about caring for the people who will be helped by what we do.

Most of all, quality is the reason we can say to 7 billion people that we know where our priorities are: It all starts and ends with you. Because Our Mylan Is Your Mylan.

Therapeutic Innovation
Our worldwide research and development group includes 3,000 scientists.
Find out more

Why Generics
According to IMS Health generics contributed to U.S. health care system savings of an estimated $1.2 trillion from 2003 to 2012. And our global quality standard applies to all our medicines, no matter where they’re made.
Find out more
Last Updated  30/10/2018